Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/09/1993 | WO1993024531A1 Bnp antibody and immunoassay using it |
12/09/1993 | WO1993024530A1 Serum amyloid a protein |
12/09/1993 | WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor |
12/09/1993 | WO1993024528A1 Equine herpesvirus glycoproteins |
12/09/1993 | WO1993024527A1 Peptide inhibitors of selectin binding |
12/09/1993 | WO1993024526A1 Peptide inhibitors of selectin binding |
12/09/1993 | WO1993024525A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
12/09/1993 | WO1993024523A1 Double chain peptide compounds having hemoregulatory activity |
12/09/1993 | WO1993024521A1 Bpc peptides, their preparation and use |
12/09/1993 | WO1993024520A1 Conformationally restrained peptide analogs as antiplatelet agents |
12/09/1993 | WO1993024518A1 Design and synthesis of a cd4 beta-turn mimetic for inhibiting the binding of hiv gp120 |
12/09/1993 | WO1993024516A1 Compositions and methods for detection of hormone-binding proteins |
12/09/1993 | WO1993024515A1 Human neuropeptide y/peptide yy receptor of the y1-type and antisense oligonucleotides thereto which inhibit vasoconstriction |
12/09/1993 | WO1993024514A1 D-type cyclin and uses related thereto |
12/09/1993 | WO1993024513A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof |
12/09/1993 | WO1993024146A1 Anti-haemophilus influenza immunoprotein |
12/09/1993 | WO1993024145A1 Compositions useful in diagnosis and prophylaxis of lyme disease |
12/09/1993 | WO1993024141A1 Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material |
12/09/1993 | WO1993024139A1 Antibiotic cryptdin peptides and methods of their use |
12/09/1993 | WO1993024138A1 Biologically active peptides having n-terminal substitutions |
12/09/1993 | WO1993024136A1 Tumor killing effects of enterotoxins, superantigens, and related compounds |
12/09/1993 | WO1993024135A1 Novel cytokine that binds cd30 |
12/09/1993 | WO1993024000A1 Methods for obtaining and purifying cell-free pneumococcal surface proteins from s. pneumoniae and use thereof |
12/09/1993 | WO1993022459A3 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum |
12/09/1993 | CA2137275A1 Bandage for continuous application of biologicals |
12/09/1993 | CA2137087A1 Biologically active peptides having n-terminal substitutions |
12/09/1993 | CA2136857A1 Cryptosporidium polypeptides, nucleic acid, vectors and methods of use |
12/09/1993 | CA2136844A1 Peptide inhibitors of selectin binding |
12/09/1993 | CA2136737A1 Method for the epigenetic regulation of protein biosynthesis by scale resonance |
12/09/1993 | CA2136719A1 Serum amyloid a protein |
12/09/1993 | CA2136624A1 Peptides of human p53 protein for use in human t cell response inducing compositions, and human p53 protein-specific cytotoxic t-lymphocytes |
12/09/1993 | CA2136428A1 Peptide inhibitors of selectin binding |
12/09/1993 | CA2136178A1 Production of streptavidin from bacillus subtilis |
12/09/1993 | CA2135800A1 Compositions useful in diagnosis and prophylaxis of lyme disease |
12/09/1993 | CA2135645A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes |
12/09/1993 | CA2135194A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof |
12/09/1993 | CA2134773A1 Methods and compositions for in vivo gene therapy |
12/09/1993 | CA2131003A1 Novel cytokine that binds cd30 |
12/08/1993 | EP0572737A2 HIV Gag-env fusion antigen |
12/08/1993 | EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy |
12/08/1993 | EP0572664A1 Human nerve cell adhesion factor l1, production thereof, and gene coding for the same |
12/08/1993 | EP0572641A1 Agent for stimulating animal cell division |
12/08/1993 | EP0572573A1 Thyroid-derived chondrocyte-stimulating factor |
12/08/1993 | EP0572553A1 Recombinant thrombin receptor and related pharmaceuticals |
12/08/1993 | EP0572547A1 SUBSTITUTED $g(a)-AMINOALDEHYDES AND DERIVATIVES |
12/08/1993 | EP0572541A1 Treatment of endotoxemia |
12/08/1993 | EP0572529A1 Aptamer specific for biomolecules and method of making |
12/08/1993 | EP0572519A1 Cell-free and whole cell ice nucleators and process for their production |
12/08/1993 | EP0572508A1 Nucleic acid encoding insulin receptor substrate-1 (irs-1), irs-1 protein, diseases, therapy associated with the metabolism of irs-1 |
12/08/1993 | EP0572505A1 Human platelet-derived growth factor receptors |
12/08/1993 | EP0572478A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
12/08/1993 | EP0572433A1 Antigen-presenting capsid with fusion ms2-coat protein |
12/08/1993 | EP0537163A4 Transformation of plants with non-structural plant virus gene sequences |
12/08/1993 | EP0417129B1 Lung growth stimulatory and inhibitory factors for carcinoma tumor cells |
12/08/1993 | EP0409858B1 Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them |
12/08/1993 | EP0267204B1 Immunopotentiation |
12/08/1993 | EP0261224B1 Synthetic htlv-iii peptides, compositions and uses thereof |
12/08/1993 | CN1079226A A novel process for preparing biologically active proteins from human urine |
12/08/1993 | CN1079225A Tnf-muteins |
12/07/1993 | US5268526 Overexpression of phytochrome in transgenic plants |
12/07/1993 | US5268463 DNA molecule |
12/07/1993 | US5268455 Process for making biologically active polypeptides based on transforming growth factor-βsequences |
12/07/1993 | US5268454 Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier |
12/07/1993 | US5268453 Tissue-selective insulin analogs |
12/07/1993 | US5268363 Administering purifying factor J |
12/07/1993 | US5268361 Hydroxyazido derivatives and related compounds as renin inhibitors |
12/07/1993 | US5268360 Opioid peptides derived from wheat proteins |
12/07/1993 | US5268358 PDGF receptor blocking peptides |
12/07/1993 | US5268297 Insecticide |
12/07/1993 | US5268296 DNA vector and recombinant host cell for production of hirullin P6 and P18 |
12/07/1993 | US5268295 Mammalian adipocyte protein p154, nucleic acids coding therefor and uses thereof |
12/07/1993 | US5268292 Infection, cell lysis, purification |
12/07/1993 | US5268284 Ribosome binding site |
12/07/1993 | US5268279 Method for producing polyglutamic acid or a salt thereof |
12/07/1993 | US5268278 Genetic expression of somatostatin as hybrid polypeptide |
12/07/1993 | US5268277 Method for the preparation of human growth hormone |
12/07/1993 | US5268276 Recombinant systems for expression of cholera B-sub-unit with the aid of foreign promoters and/or leader peptides |
12/07/1993 | US5268274 Methods and nucleic acid sequences for the expression of the cellulose synthase operon |
12/07/1993 | US5268272 Water soluble complexes |
12/07/1993 | US5268267 Using nucleic acid; hybridization |
12/07/1993 | US5268265 Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV |
12/07/1993 | US5268172 Expression of toxin |
12/07/1993 | US5268170 Administering a polypeptide |
12/07/1993 | CA1324970C Transformed shigella |
12/07/1993 | CA1324969C High level expression of proteins in yeast |
12/07/1993 | CA1324968C Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof |
12/07/1993 | CA1324967C Expression and secretion vector in yeasts, useful for preparing heterologous proteins |
12/07/1993 | CA1324954C Inhibition of cell migration with synthetic peptides |
12/04/1993 | CA2097460A1 Angiotensin ii antagonists |
12/02/1993 | DE4217929A1 Analysis of host cell shut-offs caused by picornaviruses |
12/02/1993 | CA2097385A1 Promoter for expression and use thereof |
12/01/1993 | EP0572122A2 C-terminal modified osteogenic growth polypeptides |
12/01/1993 | EP0572088A2 Modified signal sequences |
12/01/1993 | EP0571743A1 Factor regulating gene expression |
12/01/1993 | EP0571741A2 An expression plasmid for seeds |
12/01/1993 | EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
12/01/1993 | EP0571602A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
12/01/1993 | EP0571554A1 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
12/01/1993 | EP0571549A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
12/01/1993 | EP0571538A1 Structural gene of pneumococcal protein |